AstraZeneca at SITC 2026
Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website
AstraZeneca brings 2 presentations to SITC 2026 in Phoenix, and exhibits at Booth 801. Its program focuses on the regulation of new immuno-oncology agents and on how academic researchers can work with industry, including on grants. The most concrete topic is a look at its rilvegostomig bispecific antibody program.
| Organization | SITC 2026 Attendance |
|---|---|
AstraZeneca Cambridge, United Kingdom | |
Global biopharmaceutical company that discovers, develops and sells prescription medicines, with oncology among its main therapy areas. | Booth Exhibiting at Booth 801 Fri, Nov 610:00am–2:00pm · 5:00pm–7:00pmSat, Nov 710:00am–2:00pm · 6:00pm–8:10pm Workshop Wed Nov 4 2:00pm–5:00pm Biotech Regulatory Roundtable
Workshop Wed Nov 4 2:10pm–2:55pm Session Wed Nov 4 4:10pm–4:55pm Talk Thu Nov 5 10:20am–10:30am Session Thu Nov 5 12:00pm–1:30pm Talk Thu Nov 5 4:30pm–5:00pm |
Instantly find 20 buyers from AstraZeneca
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the Society for Immunotherapy of Cancer (SITC). Submit a correction